| Financial Year |
March 31 2023 |
| Monetary Funds |
4,264,416,382.00 |
| Held-for-trading Financial Assets |
1,352,208,999.00 |
| Notes Receivable |
620,162,518.00 |
| Accounts Receivable |
5,087,721,853.00 |
| Advances to Suppliers |
235,242,367.00 |
| Other Receivables |
168,352,397.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,220,087,164.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
411,970,502.00 |
| Total Current Assets |
15,546,981,431.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,977,397,993.00 |
| Investment Properties |
-- |
| Fixed Assetes |
5,742,196,289.00 |
| Under-construction Projects |
1,954,192,755.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,691,827,232.00 |
| R&D expenses |
-- |
| Goodwill |
865,351,043.00 |
| Long-Term Deferred and Prepaid Expenses |
30,659,570.00 |
| Deferred Income Tax Assets |
302,772,222.00 |
| Other Non-Current Assets |
622,114,293.00 |
| Sub-Total of Non-Current Assets |
13,368,917,575.00 |
| Total Assets |
28,915,899,006.00 |
| Short-Term Loans |
1,477,593,670.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,173,364,939.00 |
| Accounts Payable |
1,952,355,322.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
494,490,694.00 |
| Taxes Payable |
136,439,309.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
606,275,155.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
790,352,778.00 |
| Other Current Liabilities |
63,195,148.00 |
| Sub-Total of Current Liabilities |
7,520,707,193.00 |
| Long-term Loans |
4,994,131,657.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
685,308,430.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
250,142,164.00 |
| Other Non-Current Liabilities |
252,837,617.00 |
| Sub-Total of Non-Current Liabilities |
6,631,838,381.00 |
| Total Liabilities |
14,152,545,574.00 |
| Paid-In Capital(Or Share Stock) |
757,905,108.00 |
| Capital Surplus |
2,945,955,746.00 |
| Surplus Reserve |
674,929,332.00 |
| LESS:Treasury Stock |
33,653,461.00 |
| Undistributed Profits |
6,029,752,458.00 |
| Minority Stockholder's Interest |
4,350,052,785.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,413,300,647.00 |
| Owner's Equity（Stockholder's Equity） |
14,763,353,432.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,915,899,006.00 |
